These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10604413)

  • 21. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients.
    Lam KY; Law S; Tin L; Tung PH; Wong J
    Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus.
    Ikeda G; Isaji S; Chandra B; Watanabe M; Kawarada Y
    Cancer; 1999 Oct; 86(8):1396-405. PubMed ID: 10526265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological and biological characteristics of esophageal squamous cell carcinoma associated with head and neck cancer.
    Matsumoto M; Natsugoe S; Okumura H; Ishigami S; Takatori H; Nakashima H; Takao S; Aikou T
    Oncology; 2004; 67(2):98-102. PubMed ID: 15539912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multi-institutional study of immunohistochemical investigation for the roles of cyclin D1 and E-cadherin in superficial squamous cell carcinoma of the esophagus.
    Shiozaki H; Doki Y; Yamana H; Isono K
    J Surg Oncol; 2002 Mar; 79(3):166-73. PubMed ID: 11870667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity.
    Shimada Y; Watanabe G; Yamasaki S; Maeda M; Kawabe A; Kaganoi JI; Itami A; Fukumoto M; Kanda Y; Imamura M
    Eur J Cancer; 2000 May; 36(8):987-93. PubMed ID: 10885602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
    Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
    Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma.
    Peng SY; Chou SP; Hsu HC
    J Hepatol; 1998 Aug; 29(2):281-9. PubMed ID: 9722210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
    Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma.
    Morgan RJ; Newcomb PV; Hardwick RH; Alderson D
    Eur J Surg Oncol; 1999 Aug; 25(4):364-7. PubMed ID: 10419705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
    Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S
    Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information.
    Shinozaki H; Ozawa S; Ando N; Tsuruta H; Terada M; Ueda M; Kitajima M
    Clin Cancer Res; 1996 Jul; 2(7):1155-61. PubMed ID: 9816282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
    Henriksson E; Baldetorp B; Borg A; Kjellen E; Akervall J; Wennerberg J; Wahlberg P
    Acta Oncol; 2006; 45(3):300-5. PubMed ID: 16644573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of microRNA‑449a‑5p promotes esophageal squamous cell carcinoma cell proliferation via cyclin D1 regulation.
    Jiang T; Liu J; Mu J
    Mol Med Rep; 2018 Jul; 18(1):848-854. PubMed ID: 29845226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
    Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.
    Nakamura T; Hayashi K; Ota M; Ide H; Takasaki K; Mitsuhashi M
    Dis Esophagus; 2004; 17(4):315-21. PubMed ID: 15569370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expressions of cyclin D1 and p16 in hypopharyngeal squamous cell carcinoma and their clinical significance].
    Fu Z; Pan X; Lei D; Liu D; Liu W; Liu C; Wang R; Ye P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(9):406-9. PubMed ID: 17634024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cyclin D1 and p53 protein in various malignant skin tumors.
    Inohara S; Kitagawa K; Kitano Y
    Dermatology; 1996; 192(2):94-8. PubMed ID: 8829518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FBXO31 determines poor prognosis in esophageal squamous cell carcinoma.
    Kogo R; Mimori K; Tanaka F; Komune S; Mori M
    Int J Oncol; 2011 Jul; 39(1):155-9. PubMed ID: 21537837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.